BioIVT continues biospecimen buy up with Keystone Biologicals deal

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Fly_dragonfly)
(Image: Getty/Fly_dragonfly)
The provider research models and services, BioIVT, has acquired Hatboro-PA-based Keystone Biologicals, which supplies disease-state plasma, sera, and controls.

BioIVT​ Vice President of Marketing Courtney Noah, PhD, said the acquisition broadens BioIVT’s capabilities in the in vitro diagnostics (IVD) space “by providing expanded control products and Keystone Biologicals’ expertise in the collection of bulk units of disease-state and normal sera and plasma.”

Following the transaction – financial terms of which were not disclosed – Keystone Biologicals will become part of the BioIVT organization.

With the addition, BioIVT will provide ‘comprehensive’ solutions, including remnant biofluids and tissues for early drug development, clinical specimens and point-of-care services for validation studies, and disease-state plasma collected as bulk units to support IVD manufacturing requirements, said Noah.

“When it comes to diagnostic kit development and manufacturing, IVD researchers need a reliable source for control and calibrator plasma and sera,”​ she added.

Little change will be seen in the early phases of integration, though as the companies fully merge, Noah said, “we will be looking to drive operational efficiencies and customer service processes that will serve to enhance the client experience.”

BioIVT – formerly BioreclamationIVT – has made several acquisitions over the last couple years, and standardized its site processes​ to manage clinical trial data at all of its locations.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us


View more